Literature DB >> 8706636

Effect of high glucose on fetal lung maturation at different times in gestation.

I H Gewolb1.   

Abstract

Hyperglycemia has been implicated as a cause of delayed fetal lung maturation in the diabetic pregnancy. It has been previously demonstrated that high glucose levels inhibit biochemical and morphological maturation of fetal rat lung in vitro. To explore whether there is a critical period for maximal effects of high glucose, fetal rat lung explants from day 18-22 (term) were examined after culture for 44 h in media containing 10 or 100 mM glucose. Rate of choline incorporation into PC and DSPC was significantly decreased in explants derived from day 20-22 fetuses after culture with high glucose. Paradoxically, in explants derived from day 18-19 fetuses choline incorporation rate was increased. Significant decreases in total PC and DSPC were seen in the high glucose group on days 20-21; however, earlier in gestation no differences in PC and DSPC were noted, despite the higher rate of choline incorporation into PC and DSPC, suggesting an increased turnover rate. High glucose levels also resulted in significantly decreased incorporation of labeled glycerol and palmitate into PC. Morphologic analysis of right upper lobe explants revealed significant decreases in the number of type II pneumocytes and lamellar bodies per alveolar lining cell in high glucose treated explants derived from days 19-20, but not before or after that time in gestation. Prior to day 20 there were few luminal lamellar bodies in potential airspaces. By day 20, the high glucose group had significantly fewer luminal lamellar bodies, although by day 21 the difference was no longer significant. These results suggest that high glucose may have a greater inhibitory effect late in gestation and that there may be critical periods in lung development when differences in substrate availability and utilization have differing effects.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8706636     DOI: 10.3109/01902149609050847

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  7 in total

1.  Differential effects of late gestation maternal overnutrition on the regulation of surfactant maturation in fetal and postnatal life.

Authors:  Mitchell C Lock; Erin V McGillick; Sandra Orgeig; I Caroline McMillen; Beverly S Mühlhäusler; Song Zhang; Janna L Morrison
Journal:  J Physiol       Date:  2017-08-24       Impact factor: 5.182

Review 2.  Care of the infant of the diabetic mother.

Authors:  William W Hay
Journal:  Curr Diab Rep       Date:  2012-02       Impact factor: 4.810

3.  PERINATAL OUTCOMES OF PREGNANT WOMEN WITH TYPE 1 DIABETES MELLITUS: COMPARISON OF MULTIDOSE INJECTION AND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION.

Authors:  M S Beksac; E Fadiloglu; A Tanacan
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Jan-Mar       Impact factor: 0.877

4.  Evaluation of fetal diaphragm excursion and thickness in term pregnancies complicated with pre-gestational and gestational diabetes mellitus.

Authors:  Gokhan Acmaz; Fatma Ozdemir; Banu Acmaz; Yusuf Madendağ; Ilknur Çöl Madendag; Iptisam Ipek Muderris
Journal:  Reprod Health       Date:  2022-04-02       Impact factor: 3.223

Review 5.  The Prenatal Hormone Milieu in Autism Spectrum Disorder.

Authors:  Whitney Worsham; Susan Dalton; Deborah A Bilder
Journal:  Front Psychiatry       Date:  2021-07-01       Impact factor: 4.157

6.  Amniotic fluid insulin and C-peptide as predictive markers for fetal macrosomia, birth injuries, and delivery complications?

Authors:  Roland Gregor Stein; Malgorzata Meinusch; Joachim Diessner; Johannes Dietl; Arnd Hönig; Ursula Zollner
Journal:  Med Sci Monit       Date:  2014-01-15

7.  Consequences of a Maternal High-Fat Diet and Late Gestation Diabetes on the Developing Rat Lung.

Authors:  Michelle L Baack; Benjamin J Forred; Tricia D Larsen; Danielle N Jensen; Angela L Wachal; Muhammad Ali Khan; Peter F Vitiello
Journal:  PLoS One       Date:  2016-08-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.